Day: April 2, 2021

We hereby provide annual information (package) of AB “Žemaitijos pienas” for 2020 – a package of audited consolidated annual financial statements, independent auditor’s report, approval of responsible persons and annual consolidated report, as well as reports on social responsibility and compliance with corporate governance code and remuneration policy. G. Keliauskas + 370 444 22208, g.keliauskas@zpienas.lt Attachments

DALLAS, April 02, 2021 (GLOBE NEWSWIRE) — Highland Global Allocation Fund (NYSE: HGLB) (“the “Fund”) today announced the declaration of monthly distributions of $0.071 per share, payable on the dates noted below. Under the Fund’s level distribution policy, the annual distribution rate has been reset to an amount equal to 8.5% of the average of the Fund’s net asset value (“NAV”) per share, as reported for the final five trading days of the 2020 calendar year. The Fund is declaring distributions of $0.071 per month for April through June 2021. The following dates apply to the distributions declared:Ex-Date Record Date Payable DateApril 22, 2021 April 23, 2021 April 30, 2021May 21, 2021 May 24, 2021 May 31, 2021June 22, 2021 June 23, 2021 June 30, 2021About the Level Distribution Policy In March 2019, the Fund’s Board...

PALO ALTO, Calif., April 02, 2021 (GLOBE NEWSWIRE) — In the first quarter, we produced just over 180,000 vehicles and delivered nearly 185,000 vehicles. We are encouraged by the strong reception of the Model Y in China and are quickly progressing to full production capacity. The new Model S and Model X have also been exceptionally well received, with the new equipment installed and tested in Q1 and we are in the early stages of ramping production.  Production Deliveries Subject to operating lease accountingModel S/X – 2,020 6%Model 3/Y 180,338 182,780 7%Total 180,338 184,800 7% *************** Our net income and cash flow results will be announced along with the rest of our financial performance when we announce Q1 earnings. Our delivery count should be viewed as slightly conservative, as we only count a car...

  BEL2 allée de Longchamp92150 SURESNES      Suresnes, le 2 avril 2021        Information mensuelle relative au nombre total d’actions et   de droits de vote composant le capital social  Article L 233-8-II du Code de commerce et article 223-16 du Règlement général de l’AMF             Euronext Paris – FBEL – isin FR0000121857             Date d’arrêté des informations Nombre total d’actions composant le capital Nombre total de droits de vote      Nombre brut Pm : nombre net *           31/12/2020 6 872 335 13 483 146 13 399 806  31/01/2021 6 872 335 13 483 047 13 399 132  28/02/2021 6 872 335 13 482 864 13 398 853  31/03/2021 6 872 335 13 482 616 13 398 605                                                                                                   *Total...

The Ordinary General Meeting of Shareholders of AB “Žemaitijos Pienas”, which took place on 2 April 2021, heard the auditors’ report, as well as consolidated annual report for 2020 and other documents submitted to the Meeting of Shareholders and made decisions on relevant issues. Decisions and other documents are attached to this notice. Gintaras KeliauskasTel. + 37068718399,E-mail: g.keliauskas@zpienas.lt Attachments

2021 m. balandžio 02 d. įvykęs AB „Žemaitijos pienas“ eilinis visuotinis akcininkų susirinkimas išklausė  auditorių išvadą, taip pat bendrovės 2020 m. konsoliduotą metinį pranešimą ir kitus pristatytus akcininkų susirinkimui dokumentus ir atitinkamais klausimais priėmė sprendimus. Sprendimai ir kiti dokumentai pridedami prie šio pranešimo. Gintaras KeliauskasTel. + 370 68718399,el. p. g.keliauskas@zpienas.lt Priedai

ATLANTA and SAN MATEO, Calif., April 02, 2021 (GLOBE NEWSWIRE) — Operation HOPE, America’s largest nonprofit financial inclusion organization, today launched the HOPE Minority Small Business Index in collaboration with SurveyMonkey (Nasdaq: SVMK). The HOPE index is intended to quantify the experiences and hopefulness of Black small business owners and aspiring entrepreneurs. Each question touches on a different aspect of their experience, from hope for business success to mentorship, risk tolerance, their access to capital, and future outlook on systemic issues that can impede success for Black small business owners. “We are excited to collaborate with SurveyMonkey to give voice to the Black small business community, and to identify, amplify, and rectify the unique challenges they encounter on their pathway to success,” said John...

NEW YORK, April 02, 2021 (GLOBE NEWSWIRE) — Valley National Bancorp (NASDAQ:VLY), the holding company for Valley National Bank, announced that it will release its first quarter 2021 earnings before the market opens on Thursday, April 29, 2021. Valley’s President and CEO, Ira Robbins will host a conference call on Thursday, April 29th at 11:00 AM (ET) to discuss Valley’s first quarter 2021 earnings. Interested parties are invited to listen in by dialing toll-free 855-638-5437 Conference Id: 1474989. The teleconference will also be webcast live: https://edge.media-server.com/mmc/p/5gkztcw5 [edge.media-server.com] and archived on Valley’s website through Monday, May 31, 2021.   Investor presentation materials will be made available prior to the conference call at www.valley.com.  About ValleyAs the principal subsidiary of Valley National...

GAITHERSBURG, Md., April 02, 2021 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today provided an update on the evaluation of its investigational SARS-CoV-2 Immune Globulin Intravenous (Human) (COVID-HIG) for the treatment of hospitalized patients with COVID-19. The Phase 3 Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) trial, also known as INSIGHT-013, sponsored and supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), assessed the safety and efficacy of four immunoglobulin candidates plus standard of care versus placebo plus standard of care in hospitalized patients with COVID-19. Topline data from the ITAC trial demonstrated that the addition of anti-SARS-CoV-2 hyperimmunoglobulin to standard of care, inclusive of remdesivir,...